| 000 | 00957 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518082441.0 | ||
| 264 | 0 | _c20200805 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a2213-2619 | ||
| 024 | 7 |
_a10.1016/S2213-2600(19)30404-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHall, Ian P | |
| 245 | 0 | 0 |
_aFLT1: a potential therapeutic target in sepsis-associated ARDS? _h[electronic resource] |
| 260 |
_bThe Lancet. Respiratory medicine _c03 2020 |
||
| 300 |
_a219-220 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aDyspnea |
| 650 | 0 | 4 | _aGenome-Wide Association Study |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aRespiratory Distress Syndrome |
| 650 | 0 | 4 | _aSepsis |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factor Receptor-1 |
| 773 | 0 |
_tThe Lancet. Respiratory medicine _gvol. 8 _gno. 3 _gp. 219-220 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2213-2600(19)30404-7 _zAvailable from publisher's website |
| 999 |
_c30560950 _d30560950 |
||